Epigenetics of Down Syndrome
唐氏综合症的表观遗传学
基本信息
- 批准号:9898045
- 负责人:
- 金额:$ 60.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-13 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AD pathologyAddressAdultAffectAgeAge of OnsetAge-associated memory impairmentAgingAlzheimer&aposs DiseaseAmyloid Beta A4 Precursor ProteinBehavioral ParadigmBiological AgingBiological AssayBiological MarkersBone MarrowBrainCandidate Disease GeneCellsCerebrumChromosomal DuplicationChromosomesChromosomes, Human, Pair 10Chromosomes, Human, Pair 16Chromosomes, Human, Pair 21ComplexDNA MethylationDevelopmentDiseaseDissectionDown SyndromeEngineeringEpigenetic ProcessExhibitsFoundationsFutureGene DosageGeneral PopulationGenesGeneticGenetic CrossesGenetic FingerprintingsGoalsHematopoietic stem cellsHippocampus (Brain)Home environmentHumanHuman ChromosomesImmune systemImpaired cognitionIndividualKineticsLearningLinkLong-Term PotentiationMeasuresMedicalMemoryModelingMolecularMusNerve DegenerationOrthologous GeneOther GeneticsPathologyPatternPhenotypePopulationProcessReagentResearch PersonnelRoleStandardizationSynapsesSyntenic ConservationT-LymphocyteTherapeutic Studiesage relatedaging auditory systembasebisulfite sequencingcausal variantclinical phenotypedensitydosageearly onsetexperimental studygray matterhearing impairmentmolecular markermouse modelnon-geneticparent grantprematureresponsetranscriptometranscriptome sequencingtranscriptomics
项目摘要
This application is being submitted in response to NOT-OD-19-071. In our MPI R01 parent grant
“Epigenetics of Down syndrome”, we are using mouse models to address the mechanisms of altered
epigenetic patterning in Down syndrome (DS), and how the epigenetic changes can affect developmental
phenotypes. In this supplement/revision application, we propose to study epigenetic and biological aging and
the roles of these processes in co-occurring age-related conditions, using our segmental duplication mouse
models of DS, namely Dp(10)1Yey & Dp(16)1Yey, which contain segmental duplications of the regions of
mouse chromosomes 10 and 16 (Mm10, Mm16) that show conserved synteny with human chromosome 21
(Hsa21). The medically significant phenotypes to be investigated are age-related immune system alterations,
age-dependent hearing loss, and age-dependent cognitive decline (independently of Alzheimer’s disease, AD).
We believe that using the Dp(10) and Dp(16) mouse models, and Dp(16) mice with App gene dosage
normalized to disomy, we can start to use genetic dissection to help us to answer the following questions: (i)
what are the genes on Hsa21 that cause early epigenetic aging in DS? (ii) what are the genes on Hsa21 that
cause early biological aging in DS (iii) is epigenetic aging simply a useful “clock”, or do epigenetic changes
functionally influence biological aging? and (iv) does early biological aging contribute to the early onset of
immune system deficits, hearing loss, and cognitive decline (independently of AD) in DS? We have two
specific aims: (1) By methyl-seq & RNA-seq of brain and immune system cells of the above models at defined
ages, we will ask whether early epigenetic aging occurs in these segmental models, and whether this
phenomenon requires duplication of both chromosomal regions. (2) By analyzing the aforementioned clinical
phenotypes in the same mouse models at each of the same ages as in Aim 1, we will determine whether the
duplications of Hsa21 syntenic regions on Mmu10 and Mmu16 affect these age-dependent phenotypes. Like
DS in humans, App gene triplication is necessary for DS mice to exhibit Alzheimer-type neurodegeneration. By
normalizing App gene dosage to two copies in the segmental duplication mice, we will determine the impact of
early aging on cognitive decline, independently of AD pathology, by using synaptic density analysis,
hippocampal long-term potentiation and behavioral paradigms of learning and memory at successive ages.
Attaining these objectives will set the stage for identifying the Hsa21 gene ortholog(s) that cause early
epigenetic and biological aging in DS and thereby affect the age-of-onset of immune system alterations,
hearing loss, and AD-independent cognitive decline. These results will be relevant both for understanding and
ameliorating co-occurring conditions in people with DS and for ameliorating these same problems in the
general (euploid) population.
此申请是针对NOT-OD-19-071提交的。在我们的MPI R01家长资助中
《唐氏综合征的表观遗传学》,我们正在用小鼠模型来研究唐氏综合征的改变机制
唐氏综合征(DS)的表观遗传模式以及表观遗传变化如何影响发育
表型。在这一补充/修订应用中,我们建议研究表观遗传和生物衰老以及
使用我们的节段性复制小鼠,这些过程在共同发生的年龄相关疾病中的作用
DS的模型,即DP(10)1Yey和DP(16)1Yey,其中包含
小鼠10号和16号染色体(Mm10、Mm16)与人类21号染色体具有保守的同源性
(Hsa21)。要研究的具有医学意义的表型是与年龄相关的免疫系统改变,
年龄依赖性听力损失和年龄依赖性认知衰退(与阿尔茨海默病无关)。
我们认为使用DP(10)和DP(16)小鼠模型,以及DP(16)小鼠带有App基因的剂量
归一化到解剖,我们可以开始使用基因解剖来帮助我们回答以下问题:(I)
什么是Hsa21上导致DS早期表观遗传老化的基因?(Ii)Hsa21上有哪些基因
引起DS的早期生物衰老(III)表观遗传衰老仅仅是一个有用的“时钟”,还是做表观遗传变化
在功能上影响生物衰老?以及(Iv)早期生物衰老是否有助于提早发病
DS患者的免疫系统缺陷、听力损失和认知功能下降(与AD无关)?我们有两个
具体目标:(1)通过甲基-seq和rna-seq对上述模型的脑细胞和免疫系统细胞进行定义
年龄,我们将询问在这些节段性模型中是否发生早期表观遗传衰老,以及这是否
这一现象需要两个染色体区域的复制。(2)通过对前述临床病例的分析
在与目标1相同年龄的相同小鼠模型中,我们将确定是否
Mmu10和Mmu16上Hsa21共线区的重复会影响这些年龄相关的表型。喜欢
在人类中,App基因的三重复制是DS小鼠表现出阿尔茨海默型神经退行性变的必要条件。通过
将节段性复制小鼠的App基因剂量归一化为两个拷贝,我们将确定
通过使用突触密度分析,认知能力下降的早期衰老,独立于AD的病理,
海马长时程增强与不同年龄学习记忆的行为范式。
这些目标的实现将为鉴定导致早期感染的hsa21基因同源基因(S)奠定基础。
DS的表观遗传和生物老化,从而影响免疫系统改变的发病年龄,
听力损失,以及AD非依赖性认知能力下降。这些结果将对理解和
改善DS患者的共生情况并改善这些相同的问题
一般(整倍体)种群。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin Tycko其他文献
Benjamin Tycko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benjamin Tycko', 18)}}的其他基金
Identifying and characterizing functional noncoding mutations in multiple myeloma
识别和表征多发性骨髓瘤的功能性非编码突变
- 批准号:
10586759 - 财政年份:2023
- 资助金额:
$ 60.24万 - 项目类别:
DNA Elements Underlying Celiac and Crohn's Susceptibility
乳糜泻和克罗恩病易感性的 DNA 元素
- 批准号:
9664318 - 财政年份:2018
- 资助金额:
$ 60.24万 - 项目类别:
Genetic-epigenetic and aging interactions at COVID- 19 host response loci in Down syndrome and mouse models
唐氏综合症和小鼠模型中 COVID-19 宿主反应位点的遗传-表观遗传和衰老相互作用
- 批准号:
10221384 - 财政年份:2017
- 资助金额:
$ 60.24万 - 项目类别:
Targeting Cancer-Associated Myofibroblasts by DNA Hypomethylation
通过 DNA 低甲基化靶向癌症相关肌成纤维细胞
- 批准号:
8555378 - 财政年份:2011
- 资助金额:
$ 60.24万 - 项目类别:
Targeting Cancer-Associated Myofibroblasts by DNA Hypomethylation
通过 DNA 低甲基化靶向癌症相关肌成纤维细胞
- 批准号:
8256911 - 财政年份:2011
- 资助金额:
$ 60.24万 - 项目类别:
Optimizing MSNP for profiling DNA methylation in cancers and precursor lesions
优化 MSNP 以分析癌症和癌前病变中的 DNA 甲基化
- 批准号:
7902107 - 财政年份:2009
- 资助金额:
$ 60.24万 - 项目类别:
Optimizing MSNP for profiling DNA methylation in cancers and precursor lesions
优化 MSNP 以分析癌症和癌前病变中的 DNA 甲基化
- 批准号:
7660795 - 财政年份:2009
- 资助金额:
$ 60.24万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 60.24万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 60.24万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 60.24万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 60.24万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 60.24万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 60.24万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 60.24万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 60.24万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 60.24万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 60.24万 - 项目类别:
Research Grant